Heart disease, especially coronary artery disease, remains the world's leading cause of death and disability, and the bidirectional relationships between psychosocial factors, mental health, and heart disease have been a matter of great interest to a generation of epidemiologists, health psychologists, CL psychiatrists, and cardiologists. Psychosocial risk factors including but not limited to mental health problems increase heart disease risk, and heart disease increases risk for several psychiatric disorders. These disorders in turn increase risk for recurrent cardiac events and death. Meanwhile, treatment for heart disease is evolving rapidly; for the CL psychiatrist this means keeping up with the impact of new treatments on the patient's experience, and how these treatments may affect and be affected by psychiatric interventions, including medication interactions and adverse effects. Where do we stand, and where might we be going? In this session we attempt to briefly highlight key points in our current knowledge and practice of heart disease psychiatry and speculate about next steps. An illustrative case will be a stimulus for audience participation as we proceed through the following presentations.
Peter Shapiro: Introduction and Case Presentation
Lawson Wulsin: Psychosocial Epidemiology of Heart Disease
Leo Pozuelo: Treatment of Psychiatric Disorders in Cardiac Patients: What’s New?
Peter Shapiro: Does Treatment of Co-Morbid Psychiatric Disorders Change Heart Disease Prognosis?
Chrstopher Celano: Epidemiology of Positive Psychology Constructs and Association with Heart Disease
Jeff Huffman: Positive Psychology Interventions for Heart Disease Patients: Are We There Yet? Do They Work?
Audience and Panel: The Future?